Sign in

WBA on NASDAQ

Walgreens Boots Alliance

Logo: Walgreens Boots Alliance, Public domain, via Wikimedia Commons5

Defunct American drug retail company

Walgreens Boots Alliance, Inc. (WBA) was an American multinational holding company headquartered in Deerfield, Illinois. The company was formed on December 31, 2014, after Walgreens bought the 55% stake in Alliance Boots (owner of Boots UK Limited) that it did not already own. The total price of the acquisition was $4.9 billion in cash and 144.3 million common shares with fair value of $10.7 billion.3 It was founded by Charles Rudolph Walgreen, Sr.1 Its chief executive is Stefano Pessina.1 Its revenue was $133 billion in 2022.1 Wikipedia text CC BY-SA 4.0

Price unavailable

Last updated Oct 21, 2026.

Overview

$147.7BRevenue, fiscal 20246
-$8.6BNet income, fiscal 20246
Jan 1, 2015Founded1

Compare with CVS Health, Rite Aid or 111, Inc., or pick any stock.

  • TickerWBA on NASDAQ1
  • Industryretail1
  • HeadquartersDeerfield1
  • Founded inChicago1
  • Websitewww.walgreensbootsalliance.com
  • Legal formDelaware corporation1
  • Incorporated inDE7
  • Business address108 Wilmot Road, Deerfield, Il 600157
  • Filer categoryLarge accelerated filer7
  • LEI549300RPTUOIXG4LIH864
  • StatusActive4
  • LEI statusLapsed (not renewed)4
  • Registered addressC/O CORPORATION SERVICE COMPANY, 19808 Wilmington, United States4
  • Registered withDivision of Corporations, Department of State, 55800414

See how the biggest companies compare on our leaderboards

Walgreens Boots Alliance, Inc. (WBA) was an American multinational holding company headquartered in Deerfield, Illinois. The company was formed on December 31, 2014, after Walgreens bought the 55% stake in Alliance Boots (owner of Boots UK Limited) that it did not already own. The total price of the acquisition was $4.9 billion in cash and 144.3 million common shares with fair value of $10.7 billion. Walgreens had previously purchased 45% of the company for $4.0 billion and 83.4 million common shares in August 2012 with an option to purchase the remaining shares within three years. Walgreens became a subsidiary of the newly created company after the transactions were completed. In March 2025, the company announced that it had agreed to be taken private by Sycamore Partners for $10 billion. The private equity firm completed the acquisition in August and split WBA into five new companies: Walgreens, The Boots Group, VillageMD, CareCentrix and Shields Health Solutions.3

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2024

18.0%Gross margin6
-9.5%Operating margin6
-5.8%Net margin6
6.2%Revenue growth, 20246
-82.7%Return on equity6
0.77×Debt to equity6
-$363.0MFree cash flow6

Where the money goes

Where each dollar of revenue went, fiscal 2024

  • Cost of revenue80¢$121.1B
  • Selling, general and admin19¢$28.1B
  • Interest0¢$482.0M
  • Income tax1¢$1.2B

Out of $147.7B in revenue.6 The company lost money this year.

Where each dollar of operating cash went, fiscal 2024

  • Capital spending51¢$1.4B
  • Dividends paid46¢$1.3B
  • Share buybacks3¢$69.0M

Out of $1.0B of cash from operations. Spending exceeded cash from operations; the rest came from savings or borrowing.6

Financial statements

Revenue11121314156$147.7B in 2024+25% since 2017
0$50.0B$100.0B$150.0B2017: $118.2B$118.2B20172018: $131.5B$131.5B2018+11%2019: $120.1B$120.1B2019−9%2020: $122.0B$122.0B2020+2%2021: $132.5B$132.5B2021+9%2022: $132.7B$132.7B2022+0%2023: $139.1B$139.1B2023+5%2024: $147.7B$147.7B2024+6%
Gross profit11121314156$26.5B in 2024−9% since 2017
0$10.0B$20.0B$30.0B$40.0B2017: $29.2B$29.2B20172018: $30.8B$30.8B2018+6%2019: $28.2B$28.2B2019−9%2020: $26.1B$26.1B2020−7%2021: $28.1B$28.1B2021+8%2022: $28.3B$28.3B2022+1%2023: $27.1B$27.1B2023−4%2024: $26.5B$26.5B2024−2%
Operating income11121314156-$14.1B in 2024
-$20.0B-$10.0B0$10.0B2017: $5.5B$5.5B20172018: $6.3B$6.3B2018+15%2019: $4.8B$4.8B2019−24%2020: $982.0M$982.0M2020−79%2021: $2.3B$2.3B2021+138%2022: $1.4B$1.4B2022−41%2023: -$6.9B-$6.9B20232024: -$14.1B-$14.1B2024+105%
Net income11121314156-$8.6B in 2024
-$10.0B-$5.0B0$5.0B$10.0B2017: $4.1B$4.1B20172018: $5.0B$5.0B2018+23%2019: $4.0B$4.0B2019−21%2020: $456.0M$456.0M2020−89%2021: $2.5B$2.5B2021+457%2022: $4.3B$4.3B2022+71%2023: -$3.1B-$3.1B20232024: -$8.6B-$8.6B2024+180%
Fiscal year20172018201920202021202220232024
Revenue$118.2B11$131.5B12$120.1B13$122.0B14$132.5B15$132.7B6$139.1B6$147.7B6
Cost of revenue$89.1B11$100.7B12$91.9B13$95.9B14$104.4B15$104.4B6$112.0B6$121.1B6
Gross profit$29.2B11$30.8B12$28.2B13$26.1B14$28.1B15$28.3B6$27.1B6$26.5B6
Selling, general and admin$23.8B11$24.7B12$23.6B13$25.4B14$24.6B15$27.3B6$34.2B6$28.1B6
Operating income$5.5B11$6.3B12$4.8B13$982.0M14$2.3B15$1.4B6-$6.9B6-$14.1B6
Interest$693.0M11$616.0M12$650.0M13$613.0M14$905.0M15$400.0M6$580.0M6$482.0M6
Income before tax$4.0B6-$5.4B6-$14.2B6
Income tax$760.0M11$998.0M12$577.0M13$339.0M14$667.0M15-$30.0M6-$1.9B6$1.2B6
Net income$4.1B11$5.0B12$4.0B13$456.0M14$2.5B15$4.3B6-$3.1B6-$8.6B6
Earnings per share$3.8011$5.0712$4.3213$0.5214$2.9415$5.026-$3.576-$10.016
Earnings per share (diluted)$3.7811$5.0512$4.3113$0.5214$2.9315$5.016-$3.576-$10.016
Shares (weighted, basic)864.4M shares6863.2M shares6863.1M shares6
Shares (weighted, diluted)865.9M shares6863.2M shares6863.1M shares6

Compare Walgreens Boots Alliance with another company

Corporate structure

Walgreens Boots Alliance sits at the top of its group. 76 entities, 12 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Walgreens Boots Alliance

  • Silver Point Capital, L.P. Filed SCHEDULE 13G on Walgreens Boots Alliance, latest Sep 4, 2025
  • Alliance Sante Participations Ltd. Filed SCHEDULE 13D/A on Walgreens Boots Alliance, latest Aug 28, 2025
  • Alliance Sante Participations S.A. Filed SCHEDULE 13D/A on Walgreens Boots Alliance, latest Apr 29, 2025 (2 filings since Mar 7, 2025)
  • BlackRock Filed SCHEDULE 13G/A on Walgreens Boots Alliance, latest Apr 24, 2025 (4 filings since Feb 7, 2022)
  • VANGUARD GROUP INC Filed SCHEDULE 13G/A on Walgreens Boots Alliance, latest Feb 7, 2025 (5 filings since Feb 10, 2022)
  • State Street Corporation Filed SC 13G/A on Walgreens Boots Alliance, latest Oct 18, 2024 (4 filings since Feb 14, 2022)
  • Walgreens Boots Alliance Deerfield, Illinois, United States
    • ALLIANCE BOOTS HOLDINGS LIMITED London, United Kingdom
      • Boots Nottingham, United Kingdom
        • Boots Book-Lovers' Library Subsidiary · United Kingdom
        • No7 product line Subsidiary · United Kingdom
    • Alliance Boots Subsidiary · Bern, Switzerland
    • Alliance Healthcare Subsidiary
    • Alliance Healthcare Deutschland Subsidiary · Frankfurt, Germany
    • Boots Opticians Subsidiary · Nottingham
    • drugstore.com Subsidiary · Bellevue
    • Walgreens Subsidiary · Deerfield, Illinois, United States
    • Cencora Stake · 15.3% · Conshohocken, Pennsylvania, United States
      • AB FINCO LTD Subsidiary · Woking, United Kingdom
      • AB Singapore Investments Pte. Ltd. Subsidiary · Singapore
      • AH UK Holdco 1 Limited Subsidiary · United Kingdom
      • Amerisource Receivables Financial Corporation Subsidiary · Delaware, United States
      • AmerisourceBergen Drug Corporation Subsidiary · Delaware, United States
      • AmerisourceBergen Global Holdings GmbH Subsidiary · Switzerland
      • AmerisourceBergen Global Manufacturer Services GmbH Subsidiary · Switzerland
      • AmerisourceBergen Group GmbH Subsidiary · Switzerland
      • AmerisourceBergen International B.V. Subsidiary · Netherlands
      • AmerisourceBergen International Holdings LLC Subsidiary · Delaware, United States
      • AmerisourceBergen Luxembourg S.a.r.L. Subsidiary · Luxembourg
      • AmerisourceBergen Services Corporation Subsidiary · Delaware, United States
      • AmerisourceBergen Sourcing, LLC Subsidiary · Delaware, United States
      • AmerisourceBergen Specialty Group, LLC Subsidiary · Delaware, United States
      • AmerisourceBergen UK Holdings Ltd Subsidiary · United Kingdom
      • ASD Specialty Healthcare, LLC Subsidiary · California, United States
      • BEACHCOURSE LIMITED Subsidiary · Woking, United Kingdom
      • BPL Group, LLC Subsidiary · Delaware, United States
      • Cencora Global Procurement Limited Subsidiary · Ireland
      • Cencora International Financing Holdings LLC Subsidiary · Delaware, United States
      • Cencora International Holdings Inc. Subsidiary · Delaware, United States
      • International Physician Networks, L.L.C. Subsidiary · Delaware, United States
      • OTC DIRECT LIMITED Subsidiary · Chessington, United Kingdom
      • World Courier Group S.à r.l. Subsidiary · Luxembourg
    • BrightSpring Health Services, Inc. Stake · Louisville, Kentucky
    • Option Care Health, Inc. Stake · Bannockburn, Illinois, United States
    • AB Acquisitions Nederland Holdco 1 B.V. Subsidiary · Netherlands
    • Bond Drug Company of Illinois, LLC Subsidiary · Illinois, United States
    • Boots Management Services Limited Subsidiary · United Kingdom
    • BOOTS RETAIL (IRELAND) LIMITED Subsidiary · Dublin, Ireland
    • BOOTS RETAIL USA INC. Subsidiary · Wilmington, Delaware, United States
    • BOOTS UK LIMITED Subsidiary · Nottingham, United Kingdom
    • Duane Reade Subsidiary · New York, United States
    • FARMEXPERT D.C.I. SRL Subsidiary · Bucaresti, Romania
    • Farnacias Benavides S.A.B. de C.V. Subsidiary · Mexico
    • ONTARIO CI 2 LTD Subsidiary · George Town, Cayman Islands
    • ONTARIO UK 2 LIMITED Subsidiary · London, United Kingdom
    • Summit CityMD Midco, LLC Subsidiary · Delaware, United States
    • SUPERIOR ACQUISITIONS LIMITED Subsidiary · London, United Kingdom
    • SUPERIOR HOLDINGS LIMITED Subsidiary · London, United Kingdom
    • The Boots Company PLC Subsidiary · United Kingdom
    • and 22 more

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; subsidiaries, stakes and holdings from Wikidata (CC0); major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (3 companies). Each entity in the chart links to its source.

What it owns

What Walgreens Boots Alliance reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Finance-lease assets$680.0M6 Aug 31, 2024$678.0M6 Aug 31, 2023+0.3%
Operating-lease assets (leased space)$20.3B6 Aug 31, 2024$21.7B6 Aug 31, 2023−6.1%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$1.3B6 Aug 31, 2024$728.0M6 Aug 31, 2023+81.2%
Marketable securities, current$1.8B6 Aug 31, 2024$11.0M6 Aug 31, 2023+16172.7%
Stakes in other companies (equity method)$2.3B6 Aug 31, 2024$3.5B6 Aug 31, 2023−35.1%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$15.5B6 Aug 31, 2024$28.2B6 Aug 31, 2023−45.0%
Intangible assets, net (excluding goodwill)$13.0B6 Aug 31, 2024$13.6B6 Aug 31, 2023−4.9%
Indefinite-lived intangibles (excluding goodwill)$5.6B6 Aug 31, 2024$5.5B6 Aug 31, 2023+2.4%
Finite-lived intangibles, gross$10.7B6 Aug 31, 2024$10.8B6 Aug 31, 2023−0.2%
Accumulated amortization$3.4B6 Aug 31, 2024$2.6B6 Aug 31, 2023+29.5%
Finite-lived intangibles, net$7.4B6 Aug 31, 2024$8.2B6 Aug 31, 2023−9.7%

Inventory

ItemLatestA year beforeChange
Inventory, total$8.3B6 Aug 31, 2024$8.3B6 Aug 31, 2023+0.8%

Stakes and holdings (Wikidata)

Things Wikidata records the company as owning, with the share when stated.1

The story

Founded by Charles Rudolph Walgreen, Sr. on Jan 1, 2015, in Chicago.1

Leadership

Who has led Walgreens Boots Alliance, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Stefano Pessina2015–2021
  2. Rosalind Brewer2021–2023
  3. Timothy C. Wentworth2023–now

Chair

  1. Jim Skinner2015–2020
  2. Stefano Pessina2021–now

Chief financial officer

  1. Timothy R. McLevish2015
  2. George Rollo Fairweather2015–2017
  3. James Kehoe2018–2023
  4. Manmohan Mahajan2023–now

Chief operating officer

  1. Alexander W. Gourlay2016–2020
  2. Ornella Barra2016–now
200020052010201520202025
Board members and other officers (51)

Products and brands

  • pharmacy

Listed on Wikidata.1

Operations

Retail Pharmacy USA

Walgreens and Duane Reade operated within the Retail Pharmacy USA division of Walgreens Boots Alliance. Both businesses sell prescription and non-prescription drugs, and a range of household items, including personal care and beauty products. Walgreens provides access to consumer goods and services, plus pharmacy, photo department, health and wellness services in the United States through its retail drugstores. The division had 9,021 drugstores as of August 31, 2020. Walgreens runs, or ran, several online stores, such as: Beauty.com, Drugstore.com, VisionDirect.com, and Walgreens.com.

Walgreens has stores in all 50 U.S. states, the District of Columbia, Puerto Rico, and the U.S. Virgin Islands.

On October 27, 2015, Walgreens announced the purchase of competitor Rite Aid for $17.2 billion (equivalent to $22.2 billion in 2024). However, that deal was later scrapped due to antitrust concerns in favor of a $5.18 billion deal (equivalent to $6.5 billion in 2024), in which Walgreens only acquired half of Rite Aid locations.

On September 19, 2017, the Federal Trade Commission approved a fourth deal agreement to purchase 1,932 Rite Aid stores for $4.38 billion total (equivalent to $5.5 billion in 2024), which was completed in January 2018.

Read the full text

In June 2024, Walgreens announced that only 75% of its 8,600 U.S. locations were profitable and that the company was planning to shutter more than 2,000 locations by the year 2027. The stock price of Walgreens Boots Alliance (WBA) fell by more than 55% between January and July of 2024.

Retail Pharmacy International

Boots formed the main part of the Retail Pharmacy International division of the company. The Boots brand has a history stretching back over 170 years in the United Kingdom (UK) and is a familiar sight on Britain's high streets. Stores are located in prominent high street and city center locations as well as in local communities. Most branches include a pharmacy and focus on healthcare, personal care, and cosmetic products, with most stores selling over-the-counter medicines. Larger stores typically offer a variety of healthcare services in addition to dispensing prescriptions, and chlamydia testing and treatment (private service). Optician services are also offered in many larger stores, with Boots Opticians providing eye tests along with the sale of spectacles and contact lenses.

Many stores also feature traditional photo processing and/or a Cewe picture kiosk where users of digital cameras and camera phones can create prints via Bluetooth, USB, or CD. Larger stores usually offer a range of electrical equipment such as hairdryers, curlers, and foot massagers, while selected stores offer a range of sandwiches, baguettes, wraps, salads, and beverages.

Since 1936, there have been Boots stores outside the UK. Stores in countries as widely spread as New Zealand, Canada (see Pharma Plus), and France were all closed in the 1980s. As of 2022, there are Boots-branded stores outside the UK in Ireland, Norway and Thailand, with Boots franchise operations in the Middle East and Indonesia.

The remainder of the division was made up of the pharmacies Benavides in Mexico and Farmacias Ahumada (FASA) in Chile.

Former operations

With the acquisition of Alliance Boots, the company gained a pharmaceutical wholesale division, operating twice-daily deliveries to more than 16,500 delivery points in the UK alone. Internationally, the Pharmaceutical Wholesale Division, which mainly operated under the Alliance Healthcare brand, supplied medicines, other healthcare products and related services to more than 115,000 pharmacies, doctors, health centers and hospitals each year from 306 distribution centers in 11 countries.

In June 2021, the majority of the Alliance Healthcare wholesale division was sold to AmerisourceBergen for $6.28 billion (equivalent to $7.15 billion in 2024) in cash.

Product brands

Boots produces a large number of brands, including No. 7, Soltan and Botanics, Boots Pharmaceuticals, and Boots Laboratories, that Alliance Boots and Walgreens sought to launch internationally following the first share purchase in 2012.

Launched in 1935, the No. 7 brand is best known for its anti-aging beauty serums, developed in Nottingham, England. The range comprises products designed to target the aging concerns of specific age groups. No. 7 became available in Walgreens and Duane Reade stores in the US from November 2012, beginning in Los Angeles.

Launched in 1939, Soltan markets its UVA 5-star suncare protection, a standard of protection developed by Boots and now adopted as the benchmark for suncare products in the UK. However, in both 2004 and 2015, Watchdog, a BBC consumer investigative TV program and cited on BBC News, plus the consumer Which? magazine, each did an investigation finding the SPF rating to be lower than stated on the packaging, according to their tests.

First launched in 1995, the Botanics range, developed in partnership with the Royal Botanic Gardens, Kew, uses plant extracts in a variety of products and includes a range of organic products. The Boots Botanics range is also available through third party retailers.

The Boots own brand range of products includes skincare, medicines, healthcare products, and many more. Boots Laboratories skincare range for independent pharmacy customers was launched in France and Portugal in 2008/09 and is also sold in Spain, Italy, and Germany.

Boots now owns Almus Pharmaceuticals, a brand of generic prescription drugs, launched in 2003. It is now sold in five countries and is an umbrella brand for a wide range of lower cost generic medicines. Almus placed considerable emphasis on the design of the packaging in an attempt to reduce the number of errors by the dispensing chemist and by the patient relating to incorrect dosage which can result in either a dangerous accidental overdose or an equally dangerous under dose.

Walgreens has a self-branded line of products, "Well at Walgreens".

In 2015, Walgreens Boots Alliance paid £140 million (equivalent to £186 million in 2024) for UK skincare brand Liz Earle Naturally Active, an Avon Products subsidiary since 2010. Liz Earle Beauty Co co-founder Liz Earle, 'one of the biggest names in the beauty industry' stayed on as an 'ambassador' after selling the company for an undisclosed sum and told her own Liz Earle Wellbeing magazine's website that '...alongside my new digital and print publishing venture...at the moment I'm still connected to Liz Earle Beauty Co and continue to work as a consultant to the brand that carries my name. I'm involved in new product development...' In 2012, Liz Earle announced that she had left the company.

From Wikipedia’s article on Walgreens Boots Alliance, shared under CC BY-SA 4.0.8

Subsidiaries and ownership

Subsidiaries

Also owns

Also consolidated

Subsidiaries (Exhibit 21)

  • AB Acquisitions Nederland Holdco 1 B.V. Netherlands9
  • Alliance Boots Holdings Limited England & Wales9
  • Bond Drug Company of Illinois, LLC Illinois9
  • Boots Management Services Limited England & Wales9
  • Boots Retail (Ireland) Limited Ireland9
  • Boots UK Limited England & Wales9
  • Duane Reade New York9
  • Farnacias Benavides S.A.B. de C.V. Mexico9
  • Summit CityMD Midco, LLC Delaware9
  • Superior Acquisitions Limited England & Wales9
  • Superior Holdings Limited England & Wales9
  • Village Practice Management Company, LLC Delaware9
  • WBA Investments, Inc. Delaware9
  • WBA Jersey Limited Jersey9
  • WBA Luxembourg 6 S.à r.l. Luxembourg9
  • WBA Luxembourg 7 S.à.r.l. Luxembourg9
  • WBA US 26 LLC Delaware9
  • WBAD Holdings 2 Limited England & Wales9
  • WBAD Holdings Limited England & Wales9
  • Walgreen Eastern Co., Inc. New York9
  • Walgreen Investments Co Delaware9
  • Walgreen National Corporation Illinois9
  • Walgreens Arizona Drug Co. Arizona9
  • Walgreens Boots Alliance Holdings LLC Delaware9
All 27 listed subsidiaries
  • Walgreens Boots Alliance UK 3 Limited England & Wales9
  • Walgreens Specialty Pharmacy, LLC Delaware9
  • Weybright UK 1 Limited England & Wales9

From Wikidata.1 Ownership links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); each one cites its LEI record. The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.

Acquisitions

  1. 2015Acquired Alliance Healthcare Deutschland1

Timeline

  1. Aug 28, 20258-K Entered a material agreement; Ended a material agreement; Completed an acquisition or sale82
  2. Jul 15, 20258-K Financial statements and exhibits83
  3. Jul 11, 20258-K Shareholder vote; Other events84
  4. Jul 3, 20258-K Other events85
  5. Jun 26, 20258-K Results of operations86
  6. Apr 25, 20258-K Ended a material agreement; Other events87
  7. Apr 18, 20258-K Other events88
  8. Apr 8, 20258-K Results of operations89
  9. Mar 10, 20258-K Entered a material agreement90
  10. Mar 6, 20258-K Regulation FD disclosure91
  11. Feb 25, 20258-K Other events92
  12. Feb 11, 20258-K Other events93
  13. Oct 30, 2023New chief executive Timothy C. Wentworth becomes CEO22
  14. Mar 17, 2021New chief executive Rosalind Brewer becomes CEO23
  15. Jan 20, 2015New chief executive Stefano Pessina becomes CEO1
  16. Jan 1, 2015Founded Founded in Chicago1

Calendar

When it reported results

  1. Jun 26, 2025Reported quarterly or annual results86
  2. Apr 8, 2025Reported quarterly or annual results89
  3. Jan 10, 2025Reported quarterly or annual results94
  4. Oct 15, 2024Reported quarterly or annual results95
  5. Jun 27, 2024Reported quarterly or annual results96
  6. Mar 28, 2024Reported quarterly or annual results97
  7. Jan 4, 2024Reported quarterly or annual results98
  8. Oct 12, 2023Reported quarterly or annual results99

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

422 filings to the SEC since October 2021: 7 annual reports, 12 quarterly reports, 73 major events, 230 insider forms, 17 large holders, 83 other. The latest 20:

  1. Sep 8, 202515-12G EDGAR
  2. Sep 4, 2025SCHEDULE 13G EDGAR
  3. Aug 28, 2025S-8 POS EDGAR
  4. Aug 28, 2025S-8 POS EDGAR
  5. Aug 28, 2025S-8 POS EDGAR
  6. Aug 28, 2025S-8 POS EDGAR
  7. Aug 28, 2025POSASR EDGAR
  8. Aug 28, 20254 EDGAR
  9. Aug 28, 2025SC 13E3/A EDGAR
  10. Aug 28, 20258-K EDGAR
  11. Aug 28, 2025SCHEDULE 13D/A EDGAR
  12. Aug 28, 20254 EDGAR
  13. Aug 28, 20254 EDGAR
  14. Aug 28, 20254 EDGAR
  15. Aug 28, 20254 EDGAR
  16. Aug 28, 20254 EDGAR
  17. Aug 28, 20254 EDGAR
  18. Aug 28, 20254 EDGAR
  19. Aug 28, 20254 EDGAR
  20. Aug 28, 20254 EDGAR

The 422 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

13 open-market trades by officers, directors and large owners since October 2021: 7 buys and 6 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Apr 27, 2025Pessina StefanoExecutive Chairman of BoardBuy832,258$11.01$9.2MForm 4
Apr 27, 2025Pessina StefanoExecutive Chairman of BoardSale832,258$11.01$9.2MForm 4
Apr 11, 2024Bhandari Inderpal SDirectorBuy3,000$18.05$54.1KForm 4
Apr 2, 2024Mahajan ManmohanEVP and Global CFOBuy6,000$19.38$116.3KForm 4
Jan 29, 2024JARRETT VALERIE BDirectorBuy4,456$22.44$100.0KForm 4
Jan 16, 2024SCHLICHTING NANCY MDirectorSale15,209$23.05$350.6KForm 4
Jan 5, 2024WENTWORTH TIMOTHY CChief Executive OfficerBuy10,000$24.22$242.2KForm 4
Nov 10, 2023Gates Richard P.SVP, Chief Pharmacy OfficerSale1,000$20.45$20.4KForm 4
Jun 30, 2023DRISCOLL JOHN PATRICKEVP, Pres. U.S. HealthcareBuy5,172$28.42$147.0KForm 4
Mar 29, 2023BREWER ROSALIND GCEOBuy10,000$33.95$339.5KForm 4
Nov 18, 2022Ban Kevin M.EVP, Chief Medical OfficerSale10,303$40.19$414.1KForm 4
Nov 17, 2022SCHLICHTING NANCY MDirectorSale16,570$39.89$661.0KForm 4
Nov 19, 2021SCHLICHTING NANCY MDirectorSale2,725$47.16$128.5KForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Stakes it holds

Walgreens Boots Alliance has told the SEC it owns more than 5% of 3 companies, latest first (Schedules 13D and 13G).

Members of Congress who traded it

21 trades disclosed by members of Congress. “Vs S&P since” is the stock’s change since the trade minus the S&P 500’s.

DateMemberTradeAmountVs S&P sinceFiling
Aug 27, 2025Val T. HoyleDemocratic, HouseSale$1,001 - $15,000Report
Feb 26, 2025Gilbert Ray Cisneros, Jr.Democratic, HouseSale$1,001 - $15,000Report
Feb 12, 2025Julie JohnsonDemocratic, HouseSale$1,001 - $15,000Report
Jan 15, 2025Julie JohnsonDemocratic, HouseBuy$1,001 - $15,000Report
Apr 30, 2024Tommy TubervilleRepublican, SenateSale$50,001 - $100,000Report
Mar 21, 2024Tommy TubervilleRepublican, SenateBuy$15,001 - $50,000Report
Mar 1, 2024Michael C. Burgess, HousePartial sale$1,001 - $15,000Report
Jul 25, 2023Tommy TubervilleRepublican, SenateBuy$1,001 - $15,000Report
Jun 13, 2023Tommy TubervilleRepublican, SenateBuy$15,001 - $50,000Report
Jun 12, 2023Tommy TubervilleRepublican, SenateBuy$1,001 - $15,000Report
May 26, 2023Zoe LofgrenDemocratic, HouseSale$1,001 - $15,000Report
May 8, 2023Tommy TubervilleRepublican, SenateBuy$1,001 - $15,000Report
Feb 22, 2022Marjorie Taylor GreeneRepublican, HouseBuy$1,001 - $15,000Report
Jan 12, 2022Tommy TubervilleRepublican, SenateBuy$1,001 - $15,000Report
Jun 16, 2021Marjorie Taylor GreeneRepublican, HouseBuy$1,001 - $15,000Report
Feb 16, 2021Peter Meijer, HouseSale$15,001 - $50,000Report
Sep 16, 2020Gilbert Ray Cisneros, Jr.Democratic, HouseBuy$1,001 - $15,000Report
Aug 10, 2020Dean Phillips, HouseBuy$1,001 - $15,000Report
Apr 2, 2020Dean Phillips, HouseBuy$1,001 - $15,000Report
Feb 28, 2020Dean Phillips, HouseSale$1,001 - $15,000Report
Feb 27, 2020Kevin HernRepublican, HouseSale$1,001 - $15,000Report

Members report amounts as ranges, not exact figures. Returns are price-only (no dividends).

SEC filer profile

How Walgreens Boots Alliance is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARWalgreens Boots Alliance, Inc.2
  • CIK0001618921
  • Employer ID (EIN)47-17583222
  • Filer statusLarge accelerated filer2
  • Incorporated inDelaware2
  • Fiscal year endsAugust 312
  • Industry code (SIC)5912 Retail-Drug Stores and Proprietary Stores2
  • SEC reviewing officeOffice of Trade & Services, Division of Corporation Finance2
  • Business address108 Wilmot Road, Deerfield, IL 600152
  • Phone(847) 315-25002
  • Shares outstanding865,560,675 as of Jun 19, 202517
  • Public float$15.2B as of Feb 29, 20246
  • On EDGAR sinceSep 16, 20142
  • Filings1,098 in all: 4 (539), 8-K (192), DEFA14A (46), 3 (45), 10-Q (33), SC 13D/A (28), SC 13G/A (21), 144 (15)2
    All 54 form types

    425 (15), PX14A6G (15), 424B5 (12), DEF 14A (11), 10-K (10), FWP (9), S-8 POS (7), SCHEDULE 13D/A (7), 13F-HR (6), 4/A (6), UPLOAD (6), CORRESP (5), NO ACT (5), S-3ASR (5), SC 13E3/A (5), SC 13G (5), 8-K/A (4), 10-K/A (3), 424B7 (3), ARS (3), POSASR (3), S-8 (3), SC 13D (3), SCHEDULE 13G/A (3), 25-NSE (2), 8-A12B (2), S-4/A (2), 144/A (1), 15-12G (1), 25 (1), 3/A (1), 424B3 (1), 8-K12B (1), CERT (1), CERTNYS (1), CT ORDER (1), DEFM14A (1), EFFECT (1), N-PX (1), PRE 14A (1), PREM14A (1), PRER14A (1), PX14A6N (1), S-4 (1), SC 13E3 (1), SCHEDULE 13G (1)

  • Latest filingsAnnual report (10-K) Oct 15, 2024
    Quarterly report (10-Q) Jun 26, 2025
    Proxy statement (DEF 14A) Dec 13, 2024
    Latest 8-K (8-K) Aug 28, 2025

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60
  61. 61
    Wikidata and SEC EDGARSteven Shulman, Board member
  62. 62
    Wikidata and SEC EDGARInderpal Bhandari, Board member
  63. 63
  64. 64
    Wikidata and SEC EDGARRosalind Brewer, Board member
  65. 65
    Wikidata and SEC EDGARValerie Jarrett, Board member
  66. 66
  67. 67
  68. 68
  69. 69
    Wikidata and SEC EDGARJohn Lederer, Board member
  70. 70
    Wikidata and SEC EDGARDominic Murphy, Board member
  71. 71
    Wikidata and SEC EDGARStefano Pessina, Board member
  72. 72
    Wikidata and SEC EDGARJan Babiak, Board member
  73. 73
    Wikidata and SEC EDGARDavid Brailer, Board member
  74. 74
    Wikidata and SEC EDGARGinger Graham, Board member
  75. 75
    Wikidata and SEC EDGARNancy Schlichting, Board member
  76. 76
    Wikidata and SEC EDGARJim Skinner, Board member
  77. 77
    Wikidata and SEC EDGARWilliam C. Foote, Board member
  78. 78
  79. 79
  80. 80
  81. 81
  82. 82
  83. 83
  84. 84
  85. 85
    SEC EDGAROther events
  86. 86
  87. 87
  88. 88
    SEC EDGAROther events
  89. 89
  90. 90
  91. 91
  92. 92
    SEC EDGAROther events
  93. 93
    SEC EDGAROther events
  94. 94
  95. 95
  96. 96
  97. 97
  98. 98
  99. 99
  100. 100
  101. 101
  102. 102
  103. 103
  104. 104
  105. 105
  106. 106
  107. 107
  108. 108